Organogermanium: Potential beneficial effects on the cardiovascular system
Physiological Reports · 2025-02 · 13 (3)
DOI: 10.14814/phy2.70234 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Reports, online erschienen am 04.02.2025. Verfasst von Kunihiko Aizawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK. Hauptthemen laut MEDLINE: Cardiovascular System. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Organogermanium, especially poly‐ trans ‐[(2‐carboxyethyl)germasesquioxane] (Ge‐132), has been known to enhance immune‐modulatory activities. However, the in vivo and in vitro evidence accumulated over the last 20 years reveals that Ge‐132 has unique but underappreciated multi‐functional properties that have a potential positive effect for the cardiovascular system. A hydrolysate of Ge‐132, monomeric 3‐(trihydroxygermyl)propanoic acid, forms a complex with a vicinal diol structure (i.e., having two adjacent hydroxyl groups such as the cis ‐diol and catechol groups) that exists in ribose (e.g., adenosine triphosphate), catecholamine (e.g., adrenaline), and saccharide (e.g., glucose). Additionally, Ge‐132 enhances macrophage phagocytosis and the heme catabolic pathway by upregulating key enzymes that are responsible for producing cytoprotective molecules such as biliverdin and bilirubin during the process. These multi‐functional properties exert pleiotropic physiological effects after an oral intake of Ge‐132 such as anti‐oxidation, anti‐inflammation, anti‐hypertensive, anti‐glycation, and erythrocyte lifecycle enhancement, all of which appear to assist the cardiovascular system. Of those effects, the effects on the lifecycle of erythrocyte may have an important implication for maintaining optimal vascular function, augmenting the availability of oxygen by enhancing the elimination of senescent, and damaged erythrocytes as well as promoting erythropoiesis. Human studies are warranted to determine whether these beneficial effects observed in previous studies are translated into humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK.
- NIHR Exeter Clinical Research Facility, Exeter, UK.
- Asai Germanium Research Institute Co. Ltd., Hakodate, Hokkaido, Japan.
ORCID-Profile: Kunihiko Aizawa
Zitieren
APA
Aizawa, K., Nakamura, T., Shimada, Y., Takeda, T., Azumi, J., & Shore, A. C. (2025). Organogermanium: Potential beneficial effects on the cardiovascular system. Physiological Reports, 13(3). https://doi.org/10.14814/phy2.70234
Vancouver
Aizawa K, Nakamura T, Shimada Y, Takeda T, Azumi J, Shore AC. Organogermanium: Potential beneficial effects on the cardiovascular system. Physiological Reports. 2025;13(3). doi:10.14814/phy2.70234
BibTeX
@article{Aizawa2025,
author = {Aizawa, Kunihiko and Nakamura, Takashi and Shimada, Yasuhiro and Takeda, Tomoya and Azumi, Junya and Shore, Angela C},
title = {Organogermanium: Potential beneficial effects on the cardiovascular system},
journal = {Physiological Reports},
year = {2025},
volume = {13},
number = {3},
doi = {10.14814/phy2.70234}
}
EUVIMED